Bosentan (Tracleer®) Issued by PHA’s Scientific Leadership Council Information is based on the United States Food and Drug Administration drug labeling Last Updated November[removed]WHAT IS BOSENTAN?

First Page		Document Content
Date: 2013-12-03 14:16:08 Alcohols Bosentan Pyrimidines Hypertension Sitaxentan Pulmonary hypertension Endothelin receptor antagonist Sildenafil Actelion Chemistry Organic chemistry Sulfonamides		Bosentan (Tracleer®) Issued by PHA’s Scientific Leadership Council Information is based on the United States Food and Drug Administration drug labeling Last Updated November[removed]WHAT IS BOSENTAN? Add to Reading List Source URL: www.phassociation.org Download Document from Source Website File Size: 213,94 KB Share Document on Facebook

	TRIUMPH I study: Double Blind Placebo Controlled Clinical Investigation into the Efficacy and Tolerability of Inhaled Treprostinil Sodium in Patients with Severe Pulmonary Arterial Hypertension DocID: 1oueC - View Document
	Clinical Commissioning Policy: Clinical Commissioning Policy: National policy for targeted DocID: 18zFu - View Document
	DOCX Document DocID: 16jAU - View Document
	Kwartaalbericht 4e kwartaalNovember 2005 Contents DocID: 15SVk - View Document
	ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. DocID: 15hh8 - View Document